- Home
- GNTY vs NGNE Comparison
GNTY vs NGNE Comparison
Compare GNTY & NGNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNTY
- NGNE
- Stock Information
- Founded
- GNTY 1913
- NGNE 2003
- Country
- GNTY United States
- NGNE United States
- Employees
- GNTY N/A
- NGNE N/A
- Industry
- GNTY Major Banks
- NGNE Biotechnology: Pharmaceutical Preparations
- Sector
- GNTY Finance
- NGNE Health Care
- Exchange
- GNTY Nasdaq
- NGNE Nasdaq
- Market Cap
- GNTY 407.7M
- NGNE 471.1M
- IPO Year
- GNTY 2017
- NGNE N/A
- Fundamental
- Price
- GNTY $36.06
- NGNE $34.52
- Analyst Decision
- GNTY Hold
- NGNE Strong Buy
- Analyst Count
- GNTY 3
- NGNE 6
- Target Price
- GNTY $35.00
- NGNE $63.80
- AVG Volume (30 Days)
- GNTY 17.2K
- NGNE 353.3K
- Earning Date
- GNTY 10-21-2024
- NGNE 11-15-2024
- Dividend Yield
- GNTY 2.66%
- NGNE N/A
- EPS Growth
- GNTY N/A
- NGNE N/A
- EPS
- GNTY 2.38
- NGNE 0.18
- Revenue
- GNTY $117,228,000.00
- NGNE $925,000.00
- Revenue This Year
- GNTY N/A
- NGNE N/A
- Revenue Next Year
- GNTY $4.44
- NGNE N/A
- P/E Ratio
- GNTY $15.17
- NGNE $189.06
- Revenue Growth
- GNTY N/A
- NGNE N/A
- 52 Week Low
- GNTY $27.01
- NGNE $12.49
- 52 Week High
- GNTY $37.28
- NGNE $74.49
- Technical
- Relative Strength Index (RSI)
- GNTY 57.65
- NGNE 35.74
- Support Level
- GNTY $35.12
- NGNE $35.60
- Resistance Level
- GNTY $36.35
- NGNE $43.24
- Average True Range (ATR)
- GNTY 1.17
- NGNE 6.02
- MACD
- GNTY 0.25
- NGNE -2.86
- Stochastic Oscillator
- GNTY 81.28
- NGNE 0.00
About GNTY Guaranty Bancshares Inc.
Guaranty Bancshares Inc is a bank holding company conducting banking activities through its wholly-owned subsidiary. The company provides its customers with a full array of relationship-driven commercial and consumer banking products and services, as well as mortgage, trust, and wealth management products and services that are tailored to meet the needs of small and medium-sized businesses, professionals, and individuals. It also provides other services such as Credit cards, Personal Loans, Business Checking, Treasury Management, and other related services. The company generates its revenue from interest on loans and investments, customer service and loan fees, fees related to the sale of mortgage loans, and trust and wealth management services.
About NGNE Neurogene Inc.
Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.